Merck & Co., commonly known as Merck, is a leading global pharmaceutical company. The company was founded in 1891 by George Merck in the United States. It has since grown to become one of the largest pharmaceutical companies in the world, with a focus on discovering, developing, and manufacturing prescription drugs, vaccines, and animal health products.
Merck operates in multiple therapeutic areas, including oncology, infectious diseases, cardiovascular diseases, respiratory diseases, and more. The company's extensive research and development efforts have resulted in the creation of numerous innovative drugs and treatments that have significantly impacted healthcare globally.
One of Merck's flagship drugs is Keytruda (pembrolizumab), an immunotherapy drug that has revolutionized cancer treatment. Keytruda is used in the treatment of various types of cancer, including melanoma, lung cancer, and head and neck cancer. It works by boosting the body's immune system to recognize and fight cancer cells, offering new hope to patients and improving survival rates.
Merck is listed on the New York Stock Exchange (NYSE) under the ticker symbol "MRK." The company has a strong presence worldwide, with operations in over 140 countries. It has a diverse portfolio of pharmaceuticals and vaccines, catering to the needs of patients and healthcare providers across different regions.
In addition to its pharmaceutical business, Merck also operates a division called Merck Animal Health, which focuses on providing animal health products and solutions. This division offers a range of vaccines, pharmaceuticals, and health management solutions for both companion animals and livestock, contributing to the well-being and care of animals globally.